caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1164755930

Mehmet AltanM.D.

PRACTICEMDACCSee all providers at this practice →
Medical OncologyHouston, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
84.3
Quality
70.8
Cost
67.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 450076
Hospital
REFERRAL NETWORK

Where Mehmet Altan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.

Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
YALE NEW HAVEN HOSPITAL1396
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$29K
Payment records
17
By payment type
Consulting Fee$23K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$4K
Travel and Lodging$941
Food and Beverage$425
Top paying entities
Consulting Fee$23K
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$4K
Travel and Lodging$941
Food and Beverage$425
PRESCRIBING · PART D · 2024
Total Rx claims
82
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
4
Brand share
82.9%
Top prescribed drugs
Osimertinib Mesylate37 claims
Tepotinib Hcl19 claims
Ondansetron Hcl14 claims
Alectinib Hcl12 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
301
Unique beneficiaries
—
Total services
528
Distinct HCPCS
6
Medicare payment
$54K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 393 Medical Oncology providers in TX — below median (cohort median 4,999).